“…PILG is an innovative postnatal strategy to increase lung growth during ECMO for severe CDH patients. Previous short-term application of PILG (≤1 week) suggested a benefit in lung growth, but animal studies suggested that three weeks of distention is required for sustained lung growth [10,11,14,15]. Therefore, we performed this open-label, prospective, randomized trial to assess the safety and efficacy of PILG for up to three weeks.…”